Zobrazeno 1 - 10
of 4 618
pro vyhledávání: '"β-Lactamases"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The emergence of critical-priority E. coli, carrying a wide array of resistance and virulence factors through food sources, poses a significant challenge to public health. This study aimed to investigate the potential role of oysters sold in
Externí odkaz:
https://doaj.org/article/95cbf55bbb664e10a023ae07ba9cb8df
Autor:
Yusun Zhou, Kunqi Wang, Lele Li, Hui Li, Qingwu Tian, Baosheng Ge, Yuanyuan Chi, Xiaotong Xu, Shuhui Liu, Meng Han, Tingting Zhou, Yuanqi Zhu, Qing Wang, Bing Yu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background The production of β-lactamases is the most prevalent resistance mechanism for β-lactam antibiotics in Gram-negative bacteria. Presently, over 4900 β-lactamases have been discovered, and they are categorized into hundreds of fam
Externí odkaz:
https://doaj.org/article/981e31ee914a447e994defca7f8d88df
Publikováno v:
Āsīb/shināsī-i Darmāngāhī-i Dāmpizishkī, Vol 18, Iss 70, Pp 159-169 (2024)
Externí odkaz:
https://doaj.org/article/47c0b81c86bb486bb38faefa12e7f655
Autor:
Margarita Cabello, Marta Hernández-García, Ainhize Maruri-Aransolo, Malkoa Michelena, Blanca Pérez-Viso, Manuel Ponce-Alonso, Rafael Cantón, Patricia Ruiz-Garbajosa
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 38, Iss , Pp 281-291 (2024)
Introduction: Multi-carbapenemase-producing Enterobacterales (M-CPE) are increasingly described. We characterized the M-CPE isolates prospectively recovered in our hospital (Madrid, Spain) over two years (2021–2022). Methods: We collected 796 carba
Externí odkaz:
https://doaj.org/article/66d2aa463e4740e7a54d1d2628e95b3e
Autor:
Lamiaa A. Al-Madboly, Mohamed A. Abd El-Salam, Jairo K. Bastos, Shaimaa Aboukhatwa, Rasha M. El-Morsi
Publikováno v:
Microbial Cell Factories, Vol 23, Iss 1, Pp 1-16 (2024)
Abstract β-lactam resistance is a significant global public health issue. Outbreaks of bacteria resistant to extended-spectrum β-lactams and carbapenems are serious health concerns that not only complicate medical care but also impact patient outco
Externí odkaz:
https://doaj.org/article/301f0b1e9700487dab5463f1f6f6cd94
Autor:
Noureddine Henoun Loukili, Agnes Perrin, Olivier Gaillot, Amelie Bruandet, Fabio Boudis, Boualem Sendid, Saadalla Nseir, Jean-Ralph Zahar
Publikováno v:
International Journal of Infectious Diseases, Vol 150, Iss , Pp 107274- (2025)
Objectives: Intestinal colonization with multidrug-resistant Enterobacterales (MDRE-IC) increases the risk of MDRE bloodstream infection (BSI). However, its impact on the overall risk of nosocomial Enterobacterales bloodstream infections (nE-BSIs) re
Externí odkaz:
https://doaj.org/article/853b26f90c32487086df60fce5887fc5
Publikováno v:
Food Chemistry: X, Vol 24, Iss , Pp 101950- (2024)
Lack of biorecognition elements significantly hinders the development of rapid detection methods for clavulanic acid (CA). To address this, we expressed Class A β-lactamases PC1 in vitro and demonstrated its high affinity for CA. Then we investigate
Externí odkaz:
https://doaj.org/article/0bca768a4cfa4522a2458b79b3866410
Autor:
Benson R. Kidenya, Gerald Mboowa, Ivan Sserwadda, Stephen Kanyerezi, Esther Nakafu, Inyasi Lawrence Akaro, Baraka Mkinze, Moses L. Joloba, Jeremiah Seni
Publikováno v:
New Microbes and New Infections, Vol 62, Iss , Pp 101486- (2024)
Objectives: We investigated the genomic epidemiology of extended-spectrum β-lactamase-producing Enterobacter cloacae (ESBL-Ec) isolates from patients and hospital environment to better understand their distribution to help devising effective strateg
Externí odkaz:
https://doaj.org/article/f1051b7e5f74444d9a11414559815cd5
Autor:
Maria F. Mojica, Elise T. Zeiser, Scott A. Becka, David A. Six, Greg Moeck, Krisztina M. Papp-Wallace
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT Taniborbactam (formerly VNRX-5133) is a novel, investigational boronic acid β-lactamase inhibitor. The combination of cefepime (FEP) with taniborbactam is active against Enterobacterales carrying class A, B, C, and/or D enzymes. We assessed
Externí odkaz:
https://doaj.org/article/a37186db696742128c58a99fe618b13a
Autor:
Hiva Kadkhoda, Pourya Gholizadeh, Reza Ghotaslou, Tahereh Pirzadeh, Mohammad Ahangarzadeh Rezaee, Edris Nabizadeh, Hadi Feizi, Hossein Samadi Kafil, Mohammad Aghazadeh
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background and objective(s) CRISPR-Cas is a prokaryotic adaptive immune system that protects bacteria and archaea against mobile genetic elements (MGEs) such as bacteriophages plasmids, and transposons. In this study, we aimed to assess the
Externí odkaz:
https://doaj.org/article/02330f81213d426ca56a7a6fe3e9117c